https://www.nasdaq.com/press-release/adma-biologics-adopts-limited-duration-stockholder-rights-plan-2021-12-21
https://www.nasdaq.com/press-release/adma-biologics-provides-update-on-global-intellectual-property-portfolio-2021-12-09
https://www.nasdaq.com/press-release/adma-biologics-senior-vice-president-of-plasma-services-cyndi-tolman-elected-to-ppta
https://www.nasdaq.com/press-release/adma-biologics-advances-plasma-collection-center-expansion-plans-with-opening-of-new
https://www.nasdaq.com/press-release/adma-biologics-reports-record-third-quarter-2021-financial-results-and-highlights
https://www.nasdaq.com/press-release/adma-biologics-to-report-third-quarter-2021-financial-results-on-november-10-2021
https://www.nasdaq.com/press-release/adma-biologics-announces-closing-of-%2457.5-million-public-offering-including-full
https://www.nasdaq.com/press-release/adma-biologics-announces-data-presented-at-the-2021-isirv-who-conference-2021-10-22
https://www.nasdaq.com/press-release/adma-biologics-announces-pricing-of-public-offering-for-%2450-million-of-common-stock
https://www.nasdaq.com/press-release/adma-biologics-announces-proposed-public-offering-of-common-stock-2021-10-20
https://www.nasdaq.com/press-release/adma-biologics-announces-a-poster-presentation-at-the-2021-international-society-for
https://www.nasdaq.com/press-release/adma-biologics-strengthens-its-board-of-directors-with-the-appointment-of-young-t.
https://www.nasdaq.com/press-release/adma-biologics-announces-the-presentation-of-real-world-experience-in-the-management
https://www.nasdaq.com/press-release/adma-biologics-announces-presentation-on-respiratory-viral-infections-at-idweek-2021
https://www.nasdaq.com/press-release/adma-biologics-to-virtually-participate-in-the-cantor-healthcare-conference-2021-09
https://www.nasdaq.com/press-release/adma-biologics-receives-fda-approval-for-vanrx-aseptic-fill-finish-machine-and
https://www.nasdaq.com/press-release/adma-biologics-to-virtually-participate-in-the-morgan-stanley-19th-annual-global
https://www.nasdaq.com/press-release/adma-biologics-receives-fda-approval-for-adma-biocenters-plasma-collection-facility-0
https://www.nasdaq.com/press-release/adma-biologics-reports-record-second-quarter-2021-financial-results-and-highlights
https://www.nasdaq.com/press-release/adma-biologics-advances-expansion-plans-and-opens-new-plasma-collection-center-in
https://www.nasdaq.com/press-release/adma-biologics-announces-commercial-availability-of-expanded-vial-size-offerings-for
https://www.nasdaq.com/press-release/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021-2021
https://www.nasdaq.com/press-release/adma-biologics-announces-successful-completion-of-fda-pre-approval-manufacturing
https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-the-raymond-james-human-health-innovation-virtual
https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-the-jefferies-virtual-healthcare-conference-2021-05
https://www.nasdaq.com/press-release/adma-biologics-reports-first-quarter-2021-financial-results-and-highlights-recent
https://www.nasdaq.com/press-release/adma-biologics-to-report-first-quarter-2021-financial-results-on-may-12-2021-2021-05
https://www.nasdaq.com/press-release/adma-biologics-receives-fda-approval-for-increased-ivig-production-scale-2021-04-28
https://www.nasdaq.com/press-release/adma-biologics-opens-newest-adma-biocenters-plasma-collection-facility-in-goose-creek
https://www.nasdaq.com/press-release/adma-biologics-announces-poster-presentation-highlighting-pharmacoeconomic-burden-of
https://www.nasdaq.com/press-release/adma-biologics-reports-fourth-quarter-and-full-year-2020-financial-results-2021-03-25
https://www.nasdaq.com/press-release/adma-biologics-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march
https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-the-jefferies-virtual-plasma-summit-2021-03-04
https://www.nasdaq.com/press-release/adma-biologics-expands-global-regulatory-approval-presence-and-announces-fda-approval
https://www.nasdaq.com/press-release/adma-biologics-presents-late-breaking-poster-presentation-highlighting-clinical
https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-raymond-james-institutional-investor-conference-2021
https://www.nasdaq.com/press-release/adma-biologics-receives-fda-approval-for-adma-biocenters-plasma-collection-facility
https://www.nasdaq.com/press-release/adma-biologics-receives-unique-permanent-j-code-for-ascenivtm-2021-01-26
https://www.nasdaq.com/press-release/adma-biologics-announces-preliminary-fourth-quarter-and-full-year-2020-revenues-and
https://www.nasdaq.com/press-release/adma-biologics-receives-unique-temporary-c-code-and-pass-through-payment-status-for
https://www.nasdaq.com/press-release/adma-biologics-adopts-limited-duration-stockholder-rights-plan-2020-12-16
https://www.nasdaq.com/press-release/adma-biologics-enters-into-%24100-million-credit-facility-loan-amendment-with
https://www.nasdaq.com/press-release/adma-biologics-opens-newest-adma-biocenters-plasma-collection-facility-in-maryville
https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-jefferies-2020-virtual-london-healthcare-conference
https://www.nasdaq.com/press-release/adma-biologics-reports-third-quarter-2020-financial-results-and-business-highlights
https://www.nasdaq.com/press-release/adma-biologics-to-report-third-quarter-2020-financial-results-and-business-highlights
https://www.nasdaq.com/press-release/adma-biologics-announces-presentation-on-respiratory-viral-infections-and-new-data-on
https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-morgan-stanley-virtual-healthcare-conference-2020-09
https://www.nasdaq.com/press-release/adma-biologics-highlights-launch-of-covid-19-immunoranktm-neutralization-micro-elisa
https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-upcoming-investor-conferences-2020-09-02
https://www.nasdaq.com/press-release/adma-biologics-reports-business-highlights-and-second-quarter-2020-financial-results
https://www.nasdaq.com/press-release/adma-biologics-to-report-business-highlights-and-second-quarter-2020-financial
https://www.nasdaq.com/press-release/adma-biologics-opens-its-newest-adma-biocenters-plasma-collection-facility-2020-07-06
https://www.nasdaq.com/press-release/adma-biologics-announces-martha-j.-demski-elected-to-board-of-directors-2020-06-23
https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-jefferies-virtual-healthcare-conference-2020-05-27
https://www.nasdaq.com/press-release/adma-biologics-commences-collection-of-covid-19-plasma-from-recovered-patients-2020
https://www.nasdaq.com/press-release/adma-biologics-provides-corporate-update-on-supply-chain-robustness-and-recent
https://www.nasdaq.com/press-release/adma-biologics-reports-first-quarter-2020-financial-results-and-highlights-recent
https://www.nasdaq.com/press-release/adma-biologics-to-report-first-quarter-2020-financial-results-on-may-6-2020-2020-04
https://www.nasdaq.com/press-release/adma-biologics-reports-fourth-quarter-and-full-year-2019-financial-results-and
https://www.nasdaq.com/press-release/adma-biologics-to-report-fourth-quarter-and-full-year-2019-financial-results-on-march
https://www.nasdaq.com/press-release/adma-biologics-highlights-expanded-intellectual-property-portfolio-for-specialty
https://www.nasdaq.com/press-release/adma-biologics-announces-closing-of-full-exercise-of-underwriters-option-to-purchase
https://www.nasdaq.com/press-release/adma-biologics-receives-bionj-2020-innovator-award-for-ascenivtm-2020-02-11
https://www.nasdaq.com/press-release/adma-biologics-announces-pricing-of-upsized-%2482.3-million-public-offering-of-common
https://www.nasdaq.com/press-release/adma-biologics-announces-proposed-%2475-million-public-offering-of-common-stock-2020-02
https://www.nasdaq.com/press-release/adma-biologics-announces-preliminary-fourth-quarter-and-full-year-2019-revenues-and
https://www.nasdaq.com/press-release/adma-biologics-enters-into-a-manufacturing-and-supply-agreement-to-produce-and-sell
https://www.nasdaq.com/press-release/adma-biologics-added-to-nasdaq-biotechnology-index-2019-12-17
https://www.nasdaq.com/press-release/adma-biologics-to-present-at-jefferies-2019-london-healthcare-conference-2019-11-13
https://www.nasdaq.com/press-release/adma-biologics-reports-third-quarter-2019-financial-results-and-highlights-recent
https://www.nasdaq.com/press-release/adma-biologics-announces-acceptance-to-the-plasma-protein-therapeutics-association
https://www.nasdaq.com/press-release/adma-biologics-named-company-of-the-year-by-bioflorida-2019-10-22
https://www.nasdaq.com/press-release/adma-biologics-announces-first-commercial-sales-of-ascenivtm-2019-10-21
https://www.nasdaq.com/press-release/adma-biologics-announces-publication-of-an-article-describing-the-manufacturing
https://www.nasdaq.com/press-release/adma-biologics-announces-data-presented-at-idweek-2019-2019-10-07
https://www.nasdaq.com/press-release/adma-biologics-announces-poster-presentation-at-idweek-2019-2019-10-03
https://www.nasdaq.com/press-release/adma-biologics-to-present-at-2019-cantor-global-healthcare-conference-2019-09-23
https://www.nasdaq.com/press-release/shareholder-alert%3a-purcell-julie-lefkowitz-llp-investigating-adma-biologics-inc.
https://www.nasdaq.com/press-release/adma-receives-department-health-and-human-services-us-license-2019-04-21
